糖抗原125(CA125)重組蛋白
Recombinant Carbohydrate Antigen 125 (CA125)
MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125
- 編號RPA154Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜, 分泌
- 預測分子量17.6kDa
- 實際分子量18kDa(差異分析請參閱說明書)
- 片段與標簽Leu13633~His13754 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點7.0
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1126 ¥ 2814 ¥ 5628 ¥ 16884 ¥ 42210
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA154Hu01 | 糖抗原125(CA125)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA154Hu02 | 糖抗原125(CA125)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA154Hu01 | 糖抗原125(CA125)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA154Hu02 | 糖抗原125(CA125)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA154Hu81 | 糖抗原125(CA125)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAA154Hu71 | 糖抗原125(CA125)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA154Hu22 | 糖抗原125(CA125)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA154Hu | 糖抗原125(CA125)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA154Hu | 糖抗原125(CA125)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSA154Hu01 | 糖抗原125(CA125)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. [pubmed:27755542] |
| Tumor Biology | KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis [pubmed:28651492] |
| Oncotarget | Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer [Pubmed:29484129] |
| Prognostic value of STC1 expression in ovarian cancer [] | |
| American Journal of Translational Research | Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway [Pubmed:35422913] |
留言咨詢
